Results 131 to 140 of about 874,446 (309)
ABSTRACT Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated neuropathy featuring progressive weakness, sensory deficits, and areflexia. While corticosteroids, intravenous immunoglobulin, and plasmapheresis are effective first‐line immunotherapies, a subset of patients remains treatment‐refractory.
Xueyu Zhang +8 more
wiley +1 more source
RFWD3 and translesion DNA polymerases contribute to PCNA modification-dependent DNA damage tolerance. [PDF]
Kanao R +4 more
europepmc +1 more source
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin +11 more
wiley +1 more source
Contact damage tolerance of alumina-based layered ceramics with tailored microstructures. [PDF]
Schlacher J +3 more
europepmc +1 more source
ABSTRACT Objective Super‐Refractory Status Epilepticus (SRSE) is a rare, life‐threatening neurological emergency with unclear etiology in many cases. Mitochondrial dysfunction, often due to disease‐causing genetic variants, is increasingly recognized as a cause, with each gene producing distinct pathophysiological mechanisms.
Pouria Mohammadi +2 more
wiley +1 more source
When replication forks encounter damaged DNA, cells utilize damage tolerance mechanisms to allow replication to proceed. These include translesion synthesis at the fork, postreplication gap filling, and template switching via fork reversal or homologous ...
Varandt Khodaverdian +7 more
doaj +1 more source
High strength and damage-tolerance in echinoderm stereom as a natural bicontinuous ceramic cellular solid. [PDF]
Yang T +7 more
europepmc +1 more source
Environment assisted degradation mechanisms in advanced light metals [PDF]
The general goals of the research program are to characterize alloy behavior quantitatively and to develop predictive mechanisms for environmental failure modes.
Gangloff, Richard P. +2 more
core +1 more source
Neuropsychiatric Symptoms Mimicking Dementia in a Patient Treated With Imatinib
ABSTRACT Tyrosine kinase inhibitors are the cornerstone of chronic myeloid leukemia treatment. Newer agents have more potency and a broader spectrum of action, but also a higher potential for neuropsychiatric side effects. We present a case of a patient on imatinib who developed progressive cognitive, mood, and behavioral alterations.
Ashley Jones +3 more
wiley +1 more source
PCNA Ubiquitylation: Instructive or Permissive to DNA Damage Tolerance Pathways? [PDF]
Che J, Hong X, Rao H.
europepmc +1 more source

